DK1383508T3 - Doxycyclin til behandling af acne - Google Patents

Doxycyclin til behandling af acne

Info

Publication number
DK1383508T3
DK1383508T3 DK02731267T DK02731267T DK1383508T3 DK 1383508 T3 DK1383508 T3 DK 1383508T3 DK 02731267 T DK02731267 T DK 02731267T DK 02731267 T DK02731267 T DK 02731267T DK 1383508 T3 DK1383508 T3 DK 1383508T3
Authority
DK
Denmark
Prior art keywords
acne
doxycycline
treatment
human
administering
Prior art date
Application number
DK02731267T
Other languages
Danish (da)
English (en)
Inventor
Robert A Ashley
Original Assignee
Collagenex Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23079310&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1383508(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Collagenex Pharm Inc filed Critical Collagenex Pharm Inc
Application granted granted Critical
Publication of DK1383508T3 publication Critical patent/DK1383508T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK02731267T 2001-04-05 2002-04-05 Doxycyclin til behandling af acne DK1383508T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28191601P 2001-04-05 2001-04-05

Publications (1)

Publication Number Publication Date
DK1383508T3 true DK1383508T3 (da) 2006-12-27

Family

ID=23079310

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02731267T DK1383508T3 (da) 2001-04-05 2002-04-05 Doxycyclin til behandling af acne

Country Status (12)

Country Link
EP (4) EP1383508B1 (https=)
JP (3) JP2004536046A (https=)
KR (1) KR100926326B1 (https=)
AT (1) ATE330615T1 (https=)
AU (1) AU2002303250B2 (https=)
CA (2) CA2719162C (https=)
DE (1) DE60212613T2 (https=)
DK (1) DK1383508T3 (https=)
ES (1) ES2266499T3 (https=)
NZ (1) NZ528197A (https=)
PT (1) PT1383508E (https=)
WO (1) WO2002080932A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2551708T3 (es) * 2002-01-08 2015-11-23 Paratek Pharmaceuticals, Inc. Compuestos de 4-desdimetilamino tetraciclina
US8192749B2 (en) 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
EP1494681A4 (en) * 2002-04-16 2008-08-06 Collagenex Pharm Inc PROCESS FOR THE SIMULTANEOUS TREATMENT OF OCULAR ROSACEA AND ACNE ROSACEA
WO2004091483A2 (en) 2003-04-07 2004-10-28 Shire Laboratories, Inc. Once daily formulations of tetracyclines
AU2004261143B2 (en) 2003-07-25 2009-11-05 Allergan Pharmaceuticals International Limited A doxycycline metal complex in a solid dosage form
EP1684768A4 (en) * 2003-11-06 2007-06-06 Univ New York State Res Found METHOD FOR TREATING ECCEM
US7544373B2 (en) 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US7704959B2 (en) * 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne
KR20130137696A (ko) * 2007-03-23 2013-12-17 몰레큘러 리서치 센터, 인크. 테트라사이클린류를 함유하는 항염증성 조성물 및 이의 치료 용도
WO2008121107A1 (en) * 2007-04-02 2008-10-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
WO2009138516A1 (en) * 2008-05-16 2009-11-19 Galderma Research & Development Therapy regimen for treating acne related diseases
WO2010017310A1 (en) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
KR20140146095A (ko) * 2012-04-19 2014-12-24 갈데르마 소시에떼아노님 여드름의 치료 방법
RU2557991C1 (ru) * 2014-05-19 2015-07-27 Вячеслав Владимирович Чеботарёв Способ лечения больных вульгарными угрями (акне), страдающих дисплазией соединительной ткани
CO2017001953A1 (es) * 2017-02-27 2018-08-31 Corporacion Univ Lasallista Método de encapsulación de tetraciclinas
CN111343991A (zh) * 2017-07-21 2020-06-26 阿尔米雷尔有限责任公司 非炎性病变的治疗
JP7561029B2 (ja) 2018-01-07 2024-10-03 ドクター レディズ ラボラトリーズ リミテッド 炎症性皮膚状態を処置するためのミノサイクリン
WO2020142350A1 (en) * 2019-01-04 2020-07-09 Dermata Therapeutics, Llc Compositions and methods for the treatment of skin conditions
WO2021215405A1 (ja) * 2020-04-20 2021-10-28 国立大学法人大阪大学 免疫賦活化剤、及び治療又は予防用組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3278457D1 (en) * 1981-08-27 1988-06-16 Soft Sheen Products Inc Use of carbamide peroxide for the manufacture of a medicament for treatment of acne vulgaris
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
WO1992003133A1 (en) * 1990-08-16 1992-03-05 Bloom, Leonard Topical treatment of blepharitis
US5674539A (en) * 1994-12-09 1997-10-07 Tomas; Robert E. Method of treating skin and composition
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
US5827840A (en) * 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5908838A (en) * 1998-02-19 1999-06-01 Medics Pharmaceutical Corporation Method for the treatment of acne
US6432934B1 (en) * 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
US6015804A (en) * 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
US5998390A (en) * 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
CA2343038A1 (en) * 1998-09-28 2000-04-06 Maria Emanuel Ryan A novel inhibitor of cataract formation
DE69932846T2 (de) * 1998-11-18 2007-03-15 Collagenex Pharmaceuticals, Inc. Neue 4-dedimethylaminotetracyclinderivate
JP2001072660A (ja) * 1999-09-08 2001-03-21 Welfide Corp TNF−α産生抑制剤および/またはIL−10産生促進剤

Also Published As

Publication number Publication date
EP1716856A2 (en) 2006-11-02
EP1712236A2 (en) 2006-10-18
EP1716856A3 (en) 2009-02-18
CA2440472A1 (en) 2002-10-17
DE60212613D1 (de) 2006-08-03
CA2719162A1 (en) 2002-10-17
AU2002303250B2 (en) 2006-05-25
PT1383508E (pt) 2006-11-30
KR100926326B1 (ko) 2009-11-12
EP1712236A3 (en) 2008-05-28
JP2004536046A (ja) 2004-12-02
KR20040007488A (ko) 2004-01-24
JP2010053155A (ja) 2010-03-11
DE60212613T2 (de) 2007-05-24
EP1383508A1 (en) 2004-01-28
CA2719162C (en) 2014-12-23
CA2440472C (en) 2011-01-18
EP1383508B1 (en) 2006-06-21
EP1383508A4 (en) 2005-07-06
EP2221056A1 (en) 2010-08-25
JP2011168613A (ja) 2011-09-01
WO2002080932A1 (en) 2002-10-17
ATE330615T1 (de) 2006-07-15
ES2266499T3 (es) 2007-03-01
NZ528197A (en) 2007-04-27

Similar Documents

Publication Publication Date Title
DK1383508T3 (da) Doxycyclin til behandling af acne
WO2005046618A3 (en) Methods of treating eczema
DE60142839D1 (de) Botulinum Toxin zur Behandlung von akuten Verletzungen der Skelettmuskeln
BR0308813A (pt) Tratamento de tuberculose usando derivados de pleuromutilina
DK1039887T3 (da) Anvendelse af aminothiolforbindelser til behandling af neuro- og nefrolidelser og terapeutiske toksiciteter
DK0665013T3 (da) Behandling af hyperproliferative karsygdomme
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
EA200900540A1 (ru) Замещённые соединения тетрациклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
PT1492561E (pt) Metodo para tratar disturbios da glandula mamaria
WO2003088906A3 (en) Methods of simultaneously treating ocular rosacea and acne rosacea
ES2136252T3 (es) Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa.
ATE191472T1 (de) Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen
IL162384A0 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
WO2004110151A8 (en) Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
SE9601396D0 (sv) New therapeutic treatment 2
ATE463242T1 (de) Behandlung von inkontinenz
DE60335093D1 (de) Verwendung von nichtantibakteriellen tetrazyklin-analoga und ihren formulierungen für die behandlung von bakteriellen exotoxinen
DK0968174T3 (da) Optisk aktiv 2-aminotetralin, fremgangsmåde til dets fremstilling og farmaceutiske præparater indeholdende selv samme, effektiv til forebyggelse og behandling af septisk chok
BR9710901A (pt) M-todo para o tratamento da doen-a bipolar
DE60141994D1 (de) 13-substituierte Methacyclinverbindungen
WO2006121865A3 (en) Methods of treating recurrent aphthous stomatitis
EA200100768A1 (ru) Применение 3-изоксазолидинонов и гидроксиаминокислот для лечения инфекций
UA40497A (uk) Спосіб лікування генералізованого катарального гінгівіту